Welcome to the ARCHIVE of Pharma Marketing News Special Reprint Collections. I have assembled these collections so you can get several related reprints in one pdf file. No subscription is required to order reprints or reprint collections. John Mack, Publisher & Editor editor@news.pharma-mkting.com

Multichannel Relationship Marketing

Multichannel is really a tactic that is part of a relationship marketing strategy. "Multichannel pharma marketing is conceptually relatively simple to understand, but incredibly difficult in practice," says Len Starnes, former Head of Digital Marketing & Sales, General Medicine at Bayer Schering Pharma. "That said, multichannel is not a transient phenomenon, it's here to stay." This completely NEW -- published November, 2012 -- collection of Pharma Marketing News articles, blog posts, podcasts, and survey results focuses mainly on issues related to multichannel marketing to physicians. These days, pharma marketers cannot rely solely on reaching physician clients via sales reps and print journal ads. Digital channels -- including the Web, social media, and mobile -- are increasingly being used by physicians to access information about pharma brands. Multichannel is really a tactic that is part of a relationship marketing strategy, which uses various interactive media to develop, maintain, and foster a relationship with a current and prospective customers to maximize need satisfaction, share of mind and budget, and nurture loyalty and, ultimately, advocacy of the brand of a product or service. 47 pages; published November, 2012.. Order and pay for this reprint collection now using your credit card... ONLY $12.95 Download PDF file immediately after paying:

ePharma Marketing, Volume 1

eMarketing is a challenge for the pharmaceutical industry. It is widely known that the percent of the pharmaceutical marketing budget spent in the "e" space has remained below 5% since the dawn of the commercial Internet! Many experts, however, believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet. The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement. approx. 45 pages. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'EP1FREEmnp' and download PDF file immediately:

ePharma Marketing, Volume 2, Section 1

Is Pharma eMarketing at a Tipping Point? Most predictions of pharma eMarketing "tipping" or coming of age have not materialized -- at least not so much as to put the drug industry on a par with other industries, which devote at least twice as much of their advertising budgets to the Internet as does the drug industry. Several of the articles in this section explore why this is so. You'll also find data from various sources that document the trend in pharmaceutical online spending from 2004 through the end of 2007. Also included are articles that address eMarketing return on investment (ROI) and information regarding pharmaceutical adoption of social media marketing. 38 pages; published July 21, 2008. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'EP21FREEgef' and download PDF file immediately:

ePharma Marketing, Volume 2, Section 2

Emerging Trends and What's Next While the drug industry as a whole may lag behind other industries in embracing the Internet, several individual pharmaceutical companies are more immersed than others. This section includes articles that focus on innovative Web-based applications that the drug industry currently sponsors for healthcare professionals and consumers. Some examples include defining a new role for eDetailing, engaging physicians and consumers via trusted 3rd party social networking sites, and ideas for integrating the Web into traditional pharmaceutical marketing campaigns. 27 pages; published July 21, 2008. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'EP22FREEjih' and download PDF file immediately:

Physician Education

Key Opinion Leaders, Medical Science Liaisons, & CME It's a new era for pharmaceutical company support of physician education. New guidelines and regulations from various governmental and non-governmental regulatory bodies have come into play during the past few years. The second event defining this new era was the withdrawal of Vioxx from the market in 2004 and the subsequent re-emergence of the importance of physicians as "learned intermediaries." More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals. This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process. approx. 27 pages. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'freePHYS' and download PDF file immediately:

eDetailing

Non-personal Physician Sales techniques In the rush to gain Share of Voice by increasing the frequency and reach of sales calls, pharmaceutical companies may have lost sight of the value that the "detail person" has given to physicians in past years. The declining sales force return on investment may signal that a significant adjustment will take place in how pharma companies market and sell their products to physicians. Many experts--not the least of which are the experts cited in this Special Supplement--think that eDetailing fits the bill for a solution to declining physician marketing ROI. This Special Supplement to Pharma Marketing News brings together in one convenient document several topics and case studies on eDetailing and ePromotion to physicians. The resultant collective wisdom of many experts both inside pharmaceutical companies and outside provide a frank assessment of the role and impact of eDetailing on physician marketing as well as the challenges that lie ahead. Bonus Reprints Included: Beyond the eDetail: Evolving to Educate eDetailing: Yesterday, Today and Tomorrow Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'eDFREE' and download PDF file immediately:

Sales Force Effectiveness

Increase Physician Access and Detailing Effectiveness Everyone knows that pharma sales reps are less effective than they used to be. Although the pharmaceutical sales force has doubled between 1995 and 2000, the number of audited calls has only increased by 10%. Through articles and real-world case studies this Special Supplement presents the collective wisdom of many marketing experts who offer solutions to the problem of decreasing sales rep effectiveness and decreasing return on the physician marketing dollar. The information in this Special Supplement is certain to give you a better understanding of the issues relating to physician access and how to improve the effectiveness of your physician marketing and sales campaigns. approx. 26 pages. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'freeSFE' and download PDF file immediately:

Direct-to-Consumer Advertising, Volume 1

Emerging Issues The collection of articles and commentary in this Pharma Marketing News Special Supplement chronicles the emerging issues of direct-to-consumer (DTC) advertising and presents pro and con opinions from experts on how DTC needs to adapt in the post-Vioxx marketing era. Topics include: DTC Pros and Cons, Straight-Talking DTC, Communicating Risk, Biotech DTC, Print DTC, and more. approx. 42 pages. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'DTCfree1' and download PDF file immediately:

Direct-to-Consumer Advertising, Volume 2

DTC in the New Era DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining. approx. 47 pages. Click the "Add to Cart" button to download this collection... FREE! Use Discount Code 'DTCfree2' and download PDF file immediately: